spacer
home > ebr > spring 2019 > connecting erp and rim data
PUBLICATIONS
European Biopharmaceutical Review

Connecting ERP and RIM Data

The more readily different parts of life sciences organisations can share good quality data, the greater the benefits for everyone concerned. However, all of this relies on an ability to harness the right data at the right time as a useful asset. As long as data is entered in different ways into different systems and in functional siloes, the scope for improving productivity and efficiency and delivering strategic business benefits will be limited. What other options are available and what is involved in a ‘master data management’ approach?

Improved data exchange was the subject of a recent roundtable debate among experienced industry experts. On the panel were Steve Gens, managing partner at Gens & Associates, Kelly Hnat, Principal at K2 Consulting, Jesper Kihl, Vice President for Global Regulatory Affairs at LEO Pharm, Jan Vindberg-Larsen, Senior Director and Head of Global Regulatory Affairs at Lundbeck, Erick Gaussens PhD, Chief Scientific Officer at ProductLife Group (PLG), Catherine Gambert, Senior Consultant for Regulatory Affairs and Regulatory Information at PLG, and Loetitia Jabri, Regulatory and Pharmaceutical Platforms Associate Director at PLG.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Erick Gaussens PhD is co-founder, Principal Consultant, and Chief Scientific Officer at ProductLife Group, providing deep insights into risk management and regulatory sciences in the life sciences industry, as well as expertise in cognitive science.
spacer
Eric Gaussens PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Further Expansion in San Diego to Maintain Industry-Leading Quality, Service and Flexibility

Philadelphia, PA – June 4, 2019 PCI Pharma Services (PCI), a leading biopharmaceutical outsourcing services provider, has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

 
Industry Events

CPhI Korea

21-23 August 2019, COEX, Seoul, South Korea

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals. It also hosts an extensive conference programme covering the latest trends and topics within the regional market.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement